Procter & Gamble (PG) Options Volume Hits 44,592 Contracts, Significantly Above Average
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 14 2026
0mins
Source: NASDAQ.COM
- Active Options Trading: Procter & Gamble's options volume today reached 44,592 contracts, equivalent to approximately 4.5 million shares, representing 43.1% of its average daily trading volume over the past month, indicating heightened market interest in its future performance.
- High Strike Call Options: The $145 strike call option expiring on February 20, 2026, has seen 6,089 contracts traded today, representing about 608,900 underlying shares, suggesting increased investor expectations for P&G's stock price appreciation.
- SITE Options Activity: SiteOne Landscape Supply Inc's options volume today stands at 2,449 contracts, approximately 244,900 shares, accounting for 42.6% of its average daily trading volume over the past month, reflecting growing market interest in the company.
- Bullish Call Options: The $140 strike call option for SITE expiring on February 20, 2026, has recorded a trading volume of 1,965 contracts today, representing around 196,500 shares, indicating investor confidence in the company's future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PG
Wall Street analysts forecast PG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PG is 164.50 USD with a low forecast of 150.00 USD and a high forecast of 180.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
10 Buy
7 Hold
0 Sell
Moderate Buy
Current: 147.340
Low
150.00
Averages
164.50
High
180.00
Current: 147.340
Low
150.00
Averages
164.50
High
180.00
About PG
The Procter & Gamble Company is focused on providing branded consumer packaged goods to consumers across the world. The Company’s segments include Beauty, Grooming, Health Care, Fabric & Home Care and Baby, Feminine & Family Care. The Company’s products are sold in approximately 180 countries and territories primarily through mass merchandisers, e-commerce, including social commerce channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. It also sells direct to individual consumers. It has operations in approximately 70 countries. It offers products under brands, such as Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Ariel, Downy, Gain, Tide, Always, Always Discreet, Tampax, Bounty and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of High-Yield Stock Investment Opportunities
- Stable Income from Realty Income: Realty Income boasts a dividend yield of 5.3% and has increased its monthly dividend for 30 consecutive years, reflecting its solid investment-grade balance sheet and conservative management approach, making it a cornerstone investment for conservative investors.
- Procter & Gamble's Dividend King Status: As one of the largest consumer goods companies globally, Procter & Gamble faces volume declines due to economic slowdowns, yet its 2.8% dividend yield and over 60 years of annual dividend increases make it attractive in uncertain markets.
- Pfizer's Turnaround Challenges: Pfizer offers a high dividend yield of 6.7%, but investor sentiment is low due to patent expirations and challenges in drug development; however, the company is actively acquiring promising drug pipelines to navigate current setbacks.
- Diverse Investment Options: Realty Income, Procter & Gamble, and Pfizer each present unique characteristics and yields above market averages, requiring investors to align their investment goals with these opportunities.
Continue Reading
Apple Stock Down 8.8%: Analyzing the Causes
- Poor Stock Performance: Apple has seen an 8.8% decline year-to-date, making it the second-worst performer in the Dow Jones Industrial Average, contrasting sharply with the S&P 500's 1% gain, indicating market concerns over its growth prospects.
- AI Integration Progress: Apple's joint announcement with Google to integrate Gemini models and cloud technology into its next-generation foundation models, with a Gemini-powered Siri expected in February, highlights its strategic push into AI, potentially enhancing user experience and competitive positioning.
- Improving Financials: In fiscal 2025, Apple's product revenue grew by 4.1% and services revenue surged by 13.5%, with product gross margins at 36.8% and services at an impressive 75.4%, indicating a recovery in profitability and demand.
- High Valuation: Despite improving earnings and margins, Apple's forward P/E ratio of 30.9 remains higher than competitors like Amazon and Alphabet, prompting investors to carefully assess its relative value amid uncertainties in consumer spending.
Continue Reading